Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3126789)

Published in BMC Pulm Med on May 23, 2011

Authors

Louise Ganderton1, Sue Jenkins, Kevin Gain, Robin Fowler, Peta Winship, Dianne Lunt, Eli Gabbay

Author Affiliations

1: School of Physiotherapy and Curtin Health Innovation Research Institute, Curtin University, Perth, Australia. louise.ganderton@health.wa.gov.au

Associated clinical trials:

Rehabilitation Program in Patients With Scleroderma | NCT05041868

Articles cited by this

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74

Psychophysical bases of perceived exertion. Med Sci Sports Exerc (1982) 30.13

ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol (2009) 7.94

Statistical considerations in the intent-to-treat principle. Control Clin Trials (2000) 5.77

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01

Primary pulmonary hypertension. N Engl J Med (1997) 4.97

Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation (2008) 4.12

Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation (1999) 3.71

Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation (2003) 3.01

Physical activity and the prevention of coronary heart disease. Ann Clin Res (1971) 2.77

Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation (2006) 2.67

Assessment of physical activity: an international perspective. Res Q Exerc Sport (2000) 2.63

Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation (2001) 2.28

Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.97

Detecting selection bias in randomized clinical trials. Control Clin Trials (1999) 1.96

Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation (2004) 1.79

Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev (2004) 1.70

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res (2006) 1.67

Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax (2009) 1.55

The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res (2007) 1.51

Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant (2009) 1.41

Randomisation in clinical trials. Med J Aust (2002) 1.40

Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J (2009) 1.32

Combined aerobic and resistance exercise training improves functional capacity and strength in CHF. J Appl Physiol (1985) (2000) 1.20

Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension. Circulation (2008) 1.11

Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J (2005) 1.03

Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med (2007) 0.97

Diagnostics in pulmonary hypertension. J Physiol Pharmacol (2007) 0.97

Exercise in patients with pulmonary arterial hypertension. J Cardiopulm Rehabil Prev (2008) 0.91

Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci (Lond) (2008) 0.90

Principles of exercise prescription for patients with chronic heart failure. Heart Fail Rev (2008) 0.88

[Feasibility of cardiopulmonary rehabilitation in patients with idiopathic pulmonary arterial hypertension treated with intravenous prostacyclin infusion therapy]. J Cardiol (2005) 0.85

Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J (2005) 0.85

Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006. Intern Med J (2007) 0.84

Articles by these authors

Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis (2011) 1.89

Six minute walk distance in healthy subjects aged 55-75 years. Respir Med (2005) 1.64

Implications of exercise-induced pulmonary arterial hypertension. Med Sci Sports Exerc (2011) 1.59

Five-year outcome in COPD patients after their first episode of acute exacerbation treated with non-invasive ventilation. Respirology (2010) 1.57

Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology (2011) 1.42

Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart (2012) 1.39

Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage (2010) 1.39

Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol (2012) 1.23

The use of regression equations to estimate peak work rate in people with COPD. COPD (2012) 1.07

Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan. J Heart Lung Transplant (2007) 1.06

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford) (2012) 0.95

Physiotherapy does not prevent, or hasten recovery from, ventilator-associated pneumonia in patients with acquired brain injury. Intensive Care Med (2008) 0.94

Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population. Respirology (2011) 0.93

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Res Ther (2012) 0.90

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension. BMC Pulm Med (2013) 0.90

Improvements in symptoms and quality of life following exercise training in older adults with moderate/severe persistent asthma. Respiration (2010) 0.89

Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant (2006) 0.89

The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial. Respir Res (2014) 0.87

Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. Cochrane Database Syst Rev (2013) 0.86

Feasibility of high-intensity, interval-based respiratory muscle training in COPD. Chest (2003) 0.86

Exercise intolerance in pulmonary arterial hypertension. Pulm Med (2012) 0.84

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study. Arthritis Res Ther (2012) 0.84

Accuracy and responsiveness of the stepwatch activity monitor and ActivPAL in patients with COPD when walking with and without a rollator. Disabil Rehabil (2011) 0.83

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Res Ther (2013) 0.83

The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial. BMC Pulm Med (2010) 0.82

Maintaining exercise capacity and quality of life following pulmonary rehabilitation. Respirology (2006) 0.82

The physiotherapy management of patients undergoing coronary artery surgery: A questionnaire survey. Aust J Physiother (1996) 0.82

Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation. J Cardiopulm Rehabil Prev (2013) 0.82

Sexual boundaries between physiotherapists and patients are not perceived clearly: an observational study. Aust J Physiother (2008) 0.80

Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6 minute walk distance and quality of life. Respirology (2008) 0.80

Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension. Expert Rev Pharmacoecon Outcomes Res (2011) 0.80

The effect of breathing exercises with body positioning on regional lung ventilation. Aust J Physiother (1996) 0.79

Rate and force of application of manual chest percussion by physiotherapists. Aust J Physiother (1998) 0.79

Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study. Pulm Circ (2013) 0.79

Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy? BMC Cardiovasc Disord (2010) 0.78

A comparison of the acute haemodynamic response to aerobic and resistance exercise in subjects with exercise-induced pulmonary arterial hypertension. Eur J Prev Cardiol (2012) 0.77

Xbox Kinect™ represents high intensity exercise for adults with cystic fibrosis. J Cyst Fibros (2013) 0.77

Respiratory and cardiovascular responses to manual chest percussion in normal subjects. Aust J Physiother (1998) 0.77

Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respirology (2010) 0.76

Which is the best exercise test to assess therapeutic intervention in COPD? Chron Respir Dis (2008) 0.76

Australian perspective regarding recommendations for physical activity and exercise rehabilitation in pulmonary arterial hypertension. J Multidiscip Healthc (2011) 0.76

Chronic thromboembolic pulmonary hypertension: treat the patient not the haemodynamics. Case Rep Pulmonol (2012) 0.75

Integrated care and optimal management of pulmonary arterial hypertension. J Multidiscip Healthc (2009) 0.75

Field Walking Tests Are Reliable and Responsive to Exercise Training in People With Non-Cystic Fibrosis Bronchiectasis. J Cardiopulm Rehabil Prev (2015) 0.75

Sexual professional boundaries perceived by undergraduate and graduate physiotherapists: a cross sectional survey. Physiotherapy (2013) 0.75

Evaluating the potential of group singing to enhance the well-being of older people. Australas J Ageing (2013) 0.75

Estimating endurance shuttle walk test speed using the six-minute walk test in people with chronic obstructive pulmonary disease. Chron Respir Dis (2014) 0.75

Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis Bronchiectasis. Respiration (2015) 0.75

Donor infection: an opinion on lung donor utilization. J Heart Lung Transplant (2005) 0.75

Effects of high-intensity inspiratory muscle training following a near-fatal gunshot wound. Phys Ther (2011) 0.75

Pulmonary arterial hypertension: a new era in management. Med J Aust (2003) 0.75

Obstructive sleep apnoea and nocturnal gastroesophageal reflux are common in lung transplant patients. Respirology (2008) 0.75

Recent consumption of a large meal does not affect measurements of lung function. Respirology (2010) 0.75

Comparing finger and forehead sensors to measure oxygen saturation in people with chronic obstructive pulmonary disease. Respirology (2013) 0.75